Management of perimenopause: Focus on alternative therapies

Health fraud and the resurgence of quackery in the United States: A warning to the European Union

“…Manufacturers would not be required to provide information to FDA before marketing a product. There would be no premarketing review or approval of supplement ingredients [54]. Once a dietary supplement was marketed, the FDA would bear the burden for demonstrating that the product was unsafe prior to taking any action to restrict its use [55,56].…”